| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Unité de Biologie des Régulations Immunitaires and
Unité de Biochimie Cellulaire, Institut Pasteur, Paris, France
Among bacterial toxins, the adenylate cyclase toxin of Bordetella pertussis (CyaA) has a unique mechanism of entry that consists in the direct translocation of its catalytic domain across the plasma membrane of target cell, a mechanism supposed to be independent of any endocytic pathway. Here, we report that the CyaA toxin is delivered to the cytosolic pathway for MHC class I-restricted Ag presentation. Using peritoneal macrophages as APC, we show that the OVA 257–264 CD8+ epitope genetically inserted into a detoxified CyaA (CyaA-OVA E5) is presented to CD8+ T cells by a mechanism requiring 1) proteasome processing, 2) TAP, and 3) neosynthesis of MHC class I. We demonstrate that the presentation of CyaA-OVA E5, like the translocation of CyaA into eukaryotic cells, is dependent on extracellular Ca2+ and independent of vacuolar acidification. Moreover, inhibitors of the phagocytic and macropinocytic endocytic pathways do not affect the CyaA-OVA E5 presentation. The absence of specific cellular receptors for CyaA correlates with the ability of various APC to present the recombinant CyaA toxin, including dendritic cells, macrophages, splenocytes, and lymphoid tumoral lines. Taken together, our results show that the CyaA presentation pathway is not cell type specific and is unrelated to a defined type of endocytic mechanism. Thus, it represents a new and unconventional delivery of an exogenous Ag into the conventional cytosolic pathway.
This article has been cited by other articles:
|
|
 |
|
  P. Berraondo, C. Nouze, X. Preville, D. Ladant, and C. Leclerc Eradication of Large Tumors in Mice by a Tritherapy Targeting the Innate, Adaptive, and Regulatory Components of the Immune System Cancer Res., September 15, 2007; 67(18): 8847 - 8855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. Connell, M. S. Shey, R. Seldon, M. X. Rangaka, G. van Cutsem, M. Simsova, Z. Marcekova, P. Sebo, N. Curtis, L. Diwakar, et al. Enhanced Ex Vivo Stimulation of Mycobacterium tuberculosis-Specific T Cells in Human Immunodeficiency Virus-Infected Persons via Antigen Delivery by the Bordetella pertussis Adenylate Cyclase Vector Clin. Vaccine Immunol., July 1, 2007; 14(7): 847 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Basler, J. Masin, R. Osicka, and P. Sebo Pore-Forming and Enzymatic Activities of Bordetella pertussis Adenylate Cyclase Toxin Synergize in Promoting Lysis of Monocytes Infect. Immun., April 1, 2006; 74(4): 2207 - 2214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mascarell, C. Fayolle, C. Bauche, D. Ladant, and C. Leclerc Induction of Neutralizing Antibodies and Th1-Polarized and CD4-Independent CD8+ T-Cell Responses following Delivery of Human Immunodeficiency Virus Type 1 Tat Protein by Recombinant Adenylate Cyclase of Bordetella pertussis J. Virol., August 1, 2005; 79(15): 9872 - 9884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Schlecht, J. Loucka, H. Najar, P. Sebo, and C. Leclerc Antigen Targeting to CD11b Allows Efficient Presentation of CD4+ and CD8+ T Cell Epitopes and In Vivo Th1-Polarized T Cell Priming J. Immunol., November 15, 2004; 173(10): 6089 - 6097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Vordermeier, M. Simsova, K. A. Wilkinson, R. J. Wilkinson, R. G. Hewinson, P. Sebo, and C. Leclerc Recognition of Mycobacterial Antigens Delivered by Genetically Detoxified Bordetella pertussis Adenylate Cyclase by T Cells from Cattle with Bovine Tuberculosis Infect. Immun., November 1, 2004; 72(11): 6255 - 6261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Dadaglio, S. Morel, C. Bauche, Z. Moukrim, F. A. Lemonnier, B. J. Van den Eynde, D. Ladant, and C. Leclerc Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes Int. Immunol., December 1, 2003; 15(12): 1423 - 1430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. G. Moron, P. Rueda, C. Sedlik, and C. Leclerc In Vivo, Dendritic Cells Can Cross-Present Virus-Like Particles Using an Endosome-to-Cytosol Pathway J. Immunol., September 1, 2003; 171(5): 2242 - 2250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Moingeon, C. de Taisne, and J. Almond Delivery technologies for human vaccines Br. Med. Bull., July 1, 2002; 62(1): 29 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Dadaglio, C.-M. Sun, R. Lo-Man, C. A. Siegrist, and C. Leclerc Efficient In Vivo Priming of Specific Cytotoxic T Cell Responses by Neonatal Dendritic Cells J. Immunol., March 1, 2002; 168(5): 2219 - 2224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Loucka, G. Schlecht, J. Vodolanova, C. Leclerc, and P. Sebo Delivery of a MalE CD4+-T-Cell Epitope into the Major Histocompatibility Complex Class II Antigen Presentation Pathway by Bordetella pertussis Adenylate Cyclase Infect. Immun., February 1, 2002; 70(2): 1002 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Fayolle, A. Osickova, R. Osicka, T. Henry, M.-J. Rojas, M.-F. Saron, P. Sebo, and C. Leclerc Delivery of Multiple Epitopes by Recombinant Detoxified Adenylate Cyclase of Bordetella pertussis Induces Protective Antiviral Immunity J. Virol., August 15, 2001; 75(16): 7330 - 7338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Guermonprez, N. Khelef, E. Blouin, P. Rieu, P. Ricciardi-Castagnoli, N. Guiso, D. Ladant, and C. Leclerc The Adenylate Cyclase Toxin of Bordetella pertussis Binds to Target Cells via the {{alpha}}M{beta}2 Integrin (CD11b/CD18) J. Exp. Med., April 30, 2001; 193(9): 1035 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Haicheur, E. Bismuth, S. Bosset, O. Adotevi, G. Warnier, V. Lacabanne, A. Regnault, C. Desaymard, S. Amigorena, P. Ricciardi-Castagnoli, et al. The B Subunit of Shiga Toxin Fused to a Tumor Antigen Elicits CTL and Targets Dendritic Cells to Allow MHC Class I-Restricted Presentation of Peptides Derived from Exogenous Antigens J. Immunol., September 15, 2000; 165(6): 3301 - 3308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Dadaglio, Z. Moukrim, R. Lo-Man, V. Sheshko, P. Sebo, and C. Leclerc Induction of a Polarized Th1 Response by Insertion of Multiple Copies of a Viral T-Cell Epitope into Adenylate Cyclase of Bordetella pertussis Infect. Immun., July 1, 2000; 68(7): 3867 - 3872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Basar, P. Guermonprez, M. Rojas, and C. Leclerc Delivery of CD8+ T-Cell Epitopes into Major Histocompatibility Complex Class I Antigen Presentation Pathway by Bordetella pertussis Adenylate Cyclase: Delineation of Cell Invasive Structures and Permissive Insertion Sites Infect. Immun., January 1, 2000; 68(1): 247 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Osicková, E. Maier, and R. Benz An Amphipathic alpha -Helix Including Glutamates 509 and 516 Is Crucial for Membrane Translocation of Adenylate Cyclase Toxin and Modulates Formation and Cation Selectivity of Its Membrane Channels J. Biol. Chem., December 31, 1999; 274(53): 37644 - 37650. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
